ROK
62
15
A
43
2
PM
62
-2
F
58
11
MHK
49
4
PSA
58
2
HCP
66
8
AMG
54
2
LEG
36
4
IPG
56
3
STI
14
-17
PPL
54
-5
UA
50
-9
PFE
23
7
LRCX
43
-2
MSFT
50
3
BWA
48
2
MRK
25
-2
TJX
64
2
DHI
48
4
ROK
62
15
A
43
2
PM
62
-2
F
58
11
MHK
49
4
PSA
58
2
HCP
66
8
AMG
54
2
LEG
36
4
IPG
56
3
STI
14
-17
PPL
54
-5
UA
50
-9
PFE
23
7
LRCX
43
-2
MSFT
50
3
BWA
48
2
MRK
25
-2
TJX
64
2
DHI
48
4
Financhill
Back

NeuroBo Pharmaceuticals Vs. Cytokinetics Industry Stock Comparison

Sell
22

NRBO
NeuroBo Pharmaceuticals

Last Price:
2.40
Seasonality Move:
6.18%
Sell
41

CYTK
Cytokinetics

Last Price:
49.09
Seasonality Move:
14.49%
Sell
22
NeuroBo Pharmaceuticals (NRBO) is a Sell

Is NeuroBo Pharmaceuticals a Buy, Sell or Hold?

  • The current NeuroBo Pharmaceuticals [NRBO] share price is $2.37. The Score for NRBO is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • NRBO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $49.10. The Score for CYTK is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NRBO Stock Price Chart

What is NeuroBo Pharmaceuticals's stock price today?

  • The NeuroBo Pharmaceuticals share price today is $2.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRBO is experiencing selling pressure, which indicates risk of future bearish movement.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $49.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight buying pressure.

NRBO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 40.38 Sell
Chaikin Money Flow: -15734 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.41 - 2.81) Sell
Bollinger Bands (100): (2.68 - 4.12) Sell

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.09 Sell
Relative Strength Index (14 RSI): 39.46 Sell
Chaikin Money Flow: 598609 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.21 - 55.57) Sell
Bollinger Bands (100): (52.53 - 57.27) Sell

NRBO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.38 Sell
20-day SMA: 2.56 Sell
50-day SMA: 2.81 Sell
200-day SMA: 3.85 Sell
8-day EMA: 2.41 Sell
20-day EMA: 2.53 Sell
50-day EMA: 2.82 Sell
200-day EMA: 4.7 Sell

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.32 Sell
20-day SMA: 52.83 Sell
50-day SMA: 53.63 Sell
200-day SMA: 59.51 Sell
8-day EMA: 50.87 Sell
20-day EMA: 52.43 Sell
50-day EMA: 53.54 Sell
200-day EMA: 55.31 Sell

NeuroBo Pharmaceuticals Earnings Growth & NRBO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.35 per share, and an increase next year of $0.07 per share.

NeuroBo Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):